Document is current
Any future updates will be listed below
-
Authors
Di Leo, Luca http://orcid.org/0000-0002-2419-2196
Bodemeyer, Valérie
Bosisio, Francesca M.
Claps, Giuseppina
Carretta, Marco http://orcid.org/0000-0002-8135-7188
Rizza, Salvatore http://orcid.org/0000-0001-7335-4684
Faienza, Fiorella http://orcid.org/0000-0001-6148-0333
Frias, Alex
Khan, Shawez
Bordi, Matteo http://orcid.org/0000-0001-8207-8546
Pacheco, Maria P.
Di Martino, Julie http://orcid.org/0000-0002-2163-0736
Bravo-Cordero, Jose J.
Daniel, Colin J.
Sears, Rosalie C. http://orcid.org/0000-0003-1558-2413
Donia, Marco http://orcid.org/0000-0003-4966-9752
Madsen, Daniel H.
Guldberg, Per http://orcid.org/0000-0002-4424-4803
Filomeni, Giuseppe http://orcid.org/0000-0002-2719-1412
Sauter, Thomas
Robert, Caroline http://orcid.org/0000-0002-9493-0238
De Zio, Daniela http://orcid.org/0000-0002-9454-402X
Cecconi, Francesco http://orcid.org/0000-0002-5614-4359
- License Information
-
More Information
Article History
Received: 22 July 2020
Accepted: 26 March 2021
First Online: 5 May 2021
Competing interests
: M.D. has received honoraria for lectures from Roche and Novartis. C.R. is a consultant for MSD, BMS, Roche, Novartis, Pierre Fabre, Sanofi, AstraZeneca, Pfizer. The remaining authors declare no competing interests.
